Exosome
Swiss Brand High Purity Exosome Face Skin Care Solution / Hair…
- Material / Composition
- Exosome formulation
- Volume / Specification
- 20mg + 5ml
- Package format
- 20mg + 5ml set
Product Portfolio Exosome Biologics
Exosome
Clinical Formulations & Supply
Lyophilized exosome sets positioned across five indication directions, supplied for professional use.
2 Published specifications
6 Application areas
On request Documentation basis
Exosome-based topical and professional-use solutions targeting skin repair, brightening, wrinkle care, acne care and hair and scalp care.
Available specifications
Exosome range
PDRN / Exosome
C-PDRN Premium Meso 3ml × 5
- Material / Composition
- PDRN formulation
- Volume / Specification
- 3ml × 5 bottles
- Package format
- 5 bottles × 3ml
Application areas
Where exosome are specified
Match the treatment area to the product property that makes it suitable, then confirm the specification against your protocol.
Tone brightening protocols
A dedicated brightening variant is positioned separately from repair.
Skin barrier repair
The repair variant targets barrier function rather than tone.
Wrinkle & texture care
A wrinkle-focused variant sits alongside the repair direction.
Acne-prone skin protocols
A separate acne-care variant is positioned in the range.
Hair & scalp care
The hair-growth variant extends the range beyond facial protocols.
Regenerative combination protocols
A combined C-PDRN option pairs exosome with nucleotide actives.
Selection guide
How to choose
- 01
Identify the specific indication you are buying for — brightening, repair, wrinkle care, acne care and hair and scalp care are positioned as separate variants.
- 02
Confirm the format: lyophilized powder plus solution set versus a ready-to-use serum.
- 03
Check the declared active content (e.g. 20 mg plus 5 ml solution) rather than volume alone.
- 04
Clarify the intended use classification for your market before launch.
Procurement
Key procurement factors
- Indication-specific variant selection
- Lyophilized + solution set vs ready-to-use format
- Declared active content per set
- Number of versions in the range
- Intended use classification by market
- Available product documentation
Documentation basis
This category is not covered by the published quality management certificates, which state a scope covering cross-linked hyaluronic acid dermal filler gel and medical sodium hyaluronate gel. Available documents vary by product and destination market.
Request documentation for this categoryBefore you order
Procurement checklist
Work through these points before placing a first order. Each one maps to a field on the technical specification sheet.
- Identify which indication variant your market requires
- Confirm the format (lyophilized set vs ready-to-use serum)
- Check declared active content per set, not volume alone
- Clarify the intended use classification for your destination market before launch
- Note that the published ISO certificates do not cover this category — confirm documentation separately
- Verify the storage and cold-chain requirements
- Confirm the number of variants you want to stock
- Confirm MOQ and lead time
Regulatory
Regulatory status — confirm before you commit
Exosome products sit under different regulatory frameworks depending on the market, and the position is not uniform. Buyers should establish the classification that applies to their destination market before ordering or promoting these products.
- In the United States, no exosome product has been approved by the FDA. Products making structure or function claims have been the subject of enforcement action.
- In the European Union, exosome-based products fall under advanced therapy medicinal product (ATMP) rules where they meet the definition.
- Intended-use classification, permitted labeling and import requirements vary by market and are handled separately from the quality management system certificate.
- We supply these products for professional and business channels. Market-specific documentation should be requested and reviewed before launch.
Buyer questions
Exosome FAQ
How many exosome variants are available?
The range is positioned across five directions: brightening, skin repair, wrinkle removal, acne removal and hair growth. Each is a distinct variant with its own positioning.
What format does the exosome product ship in?
The specification states a lyophilized powder plus solution set, for example 20 mg plus 5 ml.
Is exosome covered by the published ISO certificates?
No. The published quality management certificates state a scope covering cross-linked hyaluronic acid dermal filler gel and medical sodium hyaluronate gel for export. Exosome is a separate product category.
Recommended reading
Guides for this category
Clinical Science
Exosome vs PDRN: What Aesthetic Buyers Should Know
Exosome and PDRN products are frequently presented side by side in supplier catalogs as though they were two versions of the same thing. They are not. They differ in what they are, how they are classified by regulators, and — most importantly for buyers — what documentation you can legitimately hold when you import them.
Clinical Science
Skin Booster vs Dermal Filler: A Buyer's Distinction
The most expensive mistake in this category is treating a skin booster as a cheaper filler. They occupy different tissue planes, declare their active content in different units, and are bought in different quantities. A distributor that confuses them will mis-stock both lines.
Private label
Own-brand exosome?
Logo, retail box, label, leaflet and blister paper can be customized on this range. MOQ and lead time depend on the formulation and packaging combination you choose.
Request for quotation
Request a quotation for Exosome
Direct response with technical specifications, tiered quotation and country-specific documentation status.